Nothing on BMSN. It's dead meat since Regen started to trade. Yet another false promise in regards to how BMSN would trade once Regen got going. As for Regen, I think it will dive back down under .20 cents. Depending on circumstances, I'd buy and flip once it gets back up into the high 20s and mid 30s as it has done. Outside of FDA approval, which doesn't seem to be any time soon (still no word on what is holding up dcellvax unless that is tied with the GLP safety study of HemaXellerate) there isn't anything that is going to move this short of a deal being made. And most deals aren't made at conferences. Those on the other board who think that something magical is going to happen at a conference shows how much they really don't know about biotechs.
Oh, and remember the OS count for REgen had about doubled in less than a year. The argument was that Regen would soar due to lower share count but we have seen the opposite and the typical MO by Koos. Dilute dilute dilute while the pps drops.
News 
Market Data 
Discover 
